Bell's palsy treatment: Prednisolone, Acyclovir and Integrative Medicine

This CME/CE lecture will mainly review a research paper published in NEJM reporting the use of a steroid (prednisolone) and antiviral drug (acyclovir) for early treatment of Bell’s palsy.
Format

Recorded Video

Starting date

July 1
2021

Faculty

Wonsang Park
KMD, Ph.D

Credits

0.75 CME
      1 CEU

Duration

35 minutes

Price

$ 30

Overview

Learning Objectives

CME Credits

This CME/CE lecture will mainly review a research paper published in NEJM reporting the use of a steroid (prednisolone) and antiviral drug (acyclovir) for early treatment of Bell’s palsy. Background information includes epidemiology, grading scales, and pharmacotherapy and nonpharmacological treatment, including acupuncture, for Bell’s palsy. Nonpharmacological treatment for Bell’s palsy is reported as a summary of a 2016 Cochrane review.

The contents of this research article review CME/CE session are based on the following articles:
Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007;357(16):1598-607.
Wua X, Lia Y, Zhua YH, et al. Clinical Practice Guideline of Acupuncture for Bell’s Palsy. World J Tradit Chin Med. 2015;1(4):53-62.
* To understand the causes, symptoms, and diagnosis of Bell’s palsy
* To review the evidence behind the use of prednisolone and/or acyclovir for Bell’s palsy
* To learn about other integrative treatment methods that can be used alongside conventional care for Bell’s palsy
The following is activity is accredited to provide the following credits: 
  • 0.75 AMA PRA Category 1 Credits™
  • 1 CA CEU Credits

Faculty and disclosure

Wonsang Park

KMD, Ph.D
  • Specialist in Korean Medicine Rehabilitation
  • Medical Director of Gwanghwamun Jaseng Hospital of Korean Medicine
  • Director of International Affairs of the Society of Korean Medicine and the Korean Society of Chuna Manual Medicine for Spine and Nerves (KSCMM)
Wonsang Park, KMD, Ph.D has disclosed no relevant financial relationships to this activity.


Planners, Reviewers and Editors

Jinho Lee, KMD

In-Hyuk Ha, KMD
Me-riong Kim, KMD

Seungmin Kathy Lee, KMD
Young-suk Yoon, KMD
Jinhun Park, KMD

Andrew Jang, L.Ac

Ju Seok Lee

The planners, reviewers, and editors have disclosed no relevant financial relationships to this activity.

Disclosures

Jaseng Hospital of Korean Medicine requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Jaseng Hospital of Korean Medicine policies. Others involved in the planning of this activity have no relevant financial relationships. 

Disclaimer

The opinions and ideas expressed in this educational activity are solely those of the faculty and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institution(s) or Jaseng Medical Academy. Clinical judgment must guide each physician in weighing the possible risks and benefits of any diagnostics, interventions, or treatments discussed. Physicians should review manufacturers’ product information and consider these along with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to their patients.

CME Information

CME Accreditation Statement

Jaseng Hospital of Korean Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Jaseng Hospital of Korean Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit(s) commensurate with the extent of their participation in the activity.

Discussion of Off-Label Uses and Investigational Products

During the course of their presentation(s), the faculty may mention the use of the product(s) that have not been approved for the indication(s) being discussed. All faculty are instructed to notify when they are discussing unapproved uses or investigational agents. In addition, relevant slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the faculty and are not endorsed by, nor do they reflect, those of Jaseng Medical Academy.

Statement of Independence

CME activities of Jaseng Medical Academy are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Jaseng Medical Academy to develop and present CME and other educational activities in the field of Complementary and Alternative Medicine that are timely, balanced, scientifically rigorous, and that serve to improve competency, performance, and patient outcomes. To that end, we welcome your comments on areas of needs and/or gaps in your medical practice and how to better serve your needs.

Questions? If you have questions about this activity, please email [email protected] or call us at +82-2-2222-2792.

Refunds and Cancelations

Refunds

If you paid for an individual course and it is not what you were expecting, you can request a refund within 14 days of your payment. You are not eligible for a refund if you’ve completed 50% or more of the course, earned a course certificate, or 14 days have passed since your payment. However, if a course you purchased is disabled for legal or policy reasons, or in cases of system error, you are entitled to request a refund beyond the 14-day limit.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. 

Cancelations

During the course of their presentation(s), the faculty may mention the use of the product(s) that have not been approved for the indication(s) being discussed. All faculty are instructed to notify when they are discussing unapproved uses or investigational agents. In addition, relevant slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the faculty and are not endorsed by, nor do they reflect, those of Jaseng Medical Academy.

CME Instructions

There is a variable fee for participating in or receiving credit for this online educational activity. 

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. 

Follow the steps to earn CME/CE Credits:

1. Read the title page, overview and description, learning objectives, and author disclosure

2. Complete and view all education content

3. Complete the pre-test, post-test, and evaluation survey to provide feedback on the program. (Tests are not graded)

4. You may view, print, and download your certificate on your dashboard.


Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.